KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Total Liabilities (2018 - 2025)

Progyny (PGNY) has disclosed Total Liabilities for 8 consecutive years, with $226.4 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 22.35% to $226.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $226.4 million through Dec 2025, up 22.35% year-over-year, with the annual reading at $226.4 million for FY2025, 22.35% up from the prior year.
  • Total Liabilities for Q4 2025 was $226.4 million at Progyny, down from $235.2 million in the prior quarter.
  • The five-year high for Total Liabilities was $263.1 million in Q1 2025, with the low at $106.2 million in Q4 2021.
  • Average Total Liabilities over 5 years is $187.6 million, with a median of $207.2 million recorded in 2023.
  • The sharpest move saw Total Liabilities surged 190.59% in 2021, then dropped 8.93% in 2024.
  • Over 5 years, Total Liabilities stood at $106.2 million in 2021, then soared by 56.26% to $166.0 million in 2022, then increased by 22.39% to $203.2 million in 2023, then decreased by 8.93% to $185.0 million in 2024, then increased by 22.35% to $226.4 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $226.4 million, $235.2 million, and $245.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.